BHC(SH:600721) Shang Hai Zheng Quan Bao·2025-12-02 18:32Core Viewpoint - The announcement details the expiration of the "Consistent Action Agreement" among the controlling shareholders of Xinjiang Baihua Village Pharmaceutical Group Co., Ltd., which will automatically terminate on December 1, 2025, without affecting the company's management or control structure [2][4][7]. Group 1: Agreement Details - The "Consistent Action Agreement" was signed on December 2, 2024, by the controlling shareholders and their consistent action partner, stipulating that they would act in unison on significant company matters [3]. - The agreement was effective for one year and was adhered to without any violations during its term [3][4]. Group 2: Shareholding Structure - Before the termination of the agreement, the controlling shareholders collectively held 79,525,087 shares, representing 20.68% of the total share capital, with individual holdings as follows: Mi Zaiqi (34,559,429 shares, 8.99%), Mi Enhua (25,764,566 shares, 6.70%), and Yang Xiaoling (19,201,092 shares, 4.99%) [5][6]. - After the termination, the controlling shareholders will continue to hold the same number of shares, while the consistent action partner, Li Jiancheng, will no longer be considered a consistent action partner [6][7]. Group 3: Impact of Termination - The termination of the agreement will not lead to any changes in the controlling shareholders or management structure, ensuring the company's operational independence and integrity [7][8]. - The company maintains a sound corporate governance structure, and the termination does not harm the interests of the company or minority shareholders [7][8]. Group 4: Future Shareholding Actions - Following the termination, if Li Jiancheng decides to reduce his shareholding, he will comply with relevant regulations and commitments regarding share reduction [8][9]. - Any share reduction by Li Jiancheng will be subject to the same limits as those applicable to the other controlling shareholders, ensuring transparency and adherence to regulations [9][10].